Takeda Pharmaceutical Company Limited (TAKP34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 99.50 |
|---|---|
| 52-week range | 70.80 – 99.50 |
| Return, 1 month / 3 months | +1.7% / +20.9% |
| Return, 1 year / 3 years | +33.0% / +47.6% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 25.7% |
| Worst drawdown (1 year) | -19.9% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Takeda Pharmaceutical Company Limited is a pharmaceutical company based in Japan that researches, develops and makes prescription medicines. Its products treat conditions in areas such as cancer, digestive and inflammatory disease, disorders of the nervous system and rare diseases, and it also supplies vaccines. The company serves patients and healthcare providers through its own operations and partnerships in many countries around the world, and it carries out manufacturing and research at sites internationally.
Takeda Pharmaceutical Company Limited is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code TAKP34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Takeda Pharmaceutical Company Limited (TAKP34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 99.50 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 295 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.0% and over the last three months it rose 20.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.9% | ||
| 6-month return | 11.2% | ||
| 12-month return, skipping the last month | 30.7% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.9% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 66.7% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +9.9% |
|---|---|
| 1 month | +1.7% |
| 3 months | +20.9% |
| 6 months | +11.2% |
| 1 year | +33.0% |
| 3 years | +47.6% |
| 5 years | +51.4% |
Signals
| 50-day / 200-day average | 95.46 / 88.53 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | JPY 1.2428 |
| 26 Sep 2025 | JPY 1.3642 |
| 27 Mar 2025 | JPY 1.4521 |
| 26 Sep 2024 | JPY 1.5532 |
| 26 Mar 2024 | JPY 1.2479 |
| 27 Sep 2023 | JPY 1.2439 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.